federal_register: E9-30222

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
E9-30222 Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan Rule The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The supplemental NADA provides for additional vial sizes for an injectable solution of polysulfated glycosaminoglycan. 2009-12-21 2009 12 https://www.federalregister.gov/documents/2009/12/21/E9-30222/implantation-or-injectable-dosage-form-new-animal-drugs-polysulfated-glycosaminoglycan https://www.govinfo.gov/content/pkg/FR-2009-12-21/pdf/E9-30222.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The supplemental NADA provides for additional vial sizes for...

Links from other tables